Cargando…

Correlation analysis between auto-immunological and mutational profiles in myelodysplastic syndromes

OBJECTIVE AND DESIGN: Systemic-Inflammatory-Autoimmune-Diseases (SIAD) is increasingly considered in Myelodysplastic-Syndromes (MDS). In this line, we evaluated the MDS auto-immunological profile, correlating it to the mutational landscape, trying to identify a molecular-genetic trigger agent relate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cristiano, Antonio, Belardi, Riccardo, Hajrullaj, Hajro, Fabiani, Emiliano, Falconi, Giulia, Galossi, Elisa, Bernardini, Sergio, Voso, Maria Teresa, Nuccetelli, Marzia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Original Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499973/ https://www.ncbi.nlm.nih.gov/pubmed/37507570 http://dx.doi.org/10.1007/s00011-023-01773-5

Ejemplares similares

Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesis
por: Falconi, Giulia, et al.
Publicado: (2022)

Bone Marrow Microenvironment Involvement in t-MN: Focus on Mesenchymal Stem Cells
por: Falconi, Giulia, et al.
Publicado: (2023)

Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: correlations with morphology and mutational profile
por: Guarnera, Luca, et al.
Publicado: (2023)

Therapy-Related Myeloid Neoplasms: Predisposition and Clonal Evolution
por: Fabiani, Emiliano, et al.
Publicado: (2023)

De Novo and Therapy-Related Myelodysplastic Syndromes: Analogies and Differences
por: Leone, Giuseppe, et al.
Publicado: (2022)

Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes
por: Falconi, Giulia, et al.
Publicado: (2018)

From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: The Silent Way of Cancer Progression
por: Gurnari, Carmelo, et al.
Publicado: (2021)

The Role of Forkhead Box Proteins in Acute Myeloid Leukemia
por: Gurnari, Carmelo, et al.
Publicado: (2019)

Cytotoxicity and Differentiating Effect of the Poly(ADP-Ribose) Polymerase Inhibitor Olaparib in Myelodysplastic Syndromes
por: Faraoni, Isabella, et al.
Publicado: (2019)

Anti-phospholipids antibodies and immune complexes in COVID-19 patients: a putative role in disease course for anti-annexin-V antibodies
por: Cristiano, Antonio, et al.
Publicado: (2021)

Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study
por: Cherubini, Fabio, et al.
Publicado: (2021)

Correction to: Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study
por: Cherubini, Fabio, et al.
Publicado: (2021)

Therapy-related myeloid neoplasms: clinical perspectives
por: Fianchi, Luana, et al.
Publicado: (2018)

Endothelial Progenitor Cell Dysfunction in Myelodysplastic Syndromes: Possible Contribution of a Defective Vascular Niche to Myelodysplasia()()
por: Teofili, Luciana, et al.
Publicado: (2015)

New Treatments for Myelodysplastic Syndromes
por: D’Alò, Francesco, et al.
Publicado: (2010)

Myelodysplastic disorders carrying both isolated del(5q) and JAK2(V617F) mutation: concise review, with focus on lenalidomide therapy
por: Musto, Pellegrino, et al.
Publicado: (2014)

Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and Prognosis
por: Guarnera, Luca, et al.
Publicado: (2022)

Serological anti-SARS-CoV-2 neutralizing antibodies association to live virus neutralizing test titers in COVID-19 paucisymptomatic/symptomatic patients and vaccinated subjects
por: Cristiano, Antonio, et al.
Publicado: (2021)

Evaluation of serological anti-SARS-CoV-2 chemiluminescent immunoassays correlated to live virus neutralization test, for the detection of anti-RBD antibodies as a relevant alternative in COVID-19 large-scale neutralizing activity monitoring
por: Cristiano, Antonio, et al.
Publicado: (2022)

Mutational profile of ZBTB16‐RARA‐positive acute myeloid leukemia
por: Fabiani, Emiliano, et al.
Publicado: (2021)

Epigenetic Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemias
por: Leone, Giuseppe, et al.
Publicado: (2008)

Immunological Derangement in Hypocellular Myelodysplastic Syndromes
por: Serio, B, et al.
Publicado: (2014)

Evaluation of the accuracy in the mucosal detection of anti-SARS-CoV-2 antibodies in nasal secretions and saliva
por: Fiorelli, Denise, et al.
Publicado: (2023)

Myelodysplastic Syndrome Associated With Auto-Immune Inflammatory Disease in VEXAS Syndrome
por: Thomas, Vibha Taneja, et al.
Publicado: (2021)

SARS-CoV-2 infection serology: a useful tool to overcome lockdown?
por: Nuccetelli, Marzia, et al.
Publicado: (2020)

Evaluation of a new simultaneous anti-SARS-CoV-2 IgA, IgM and IgG screening automated assay based on native inactivated virus
por: Nuccetelli, Marzia, et al.
Publicado: (2021)

Antibody response to COVID-19 vaccine: A point of view that can help to optimize dose distribution
por: Pieri, Massimo, et al.
Publicado: (2022)

Clonal evolution in therapy-related neoplasms
por: Fabiani, Emiliano, et al.
Publicado: (2017)

Serum Amyloid A Protein as a useful biomarker to predict COVID-19 patients severity and prognosis
por: Pieri, Massimo, et al.
Publicado: (2021)

Surgical treatment for myelodysplastic clubfoot()()
por: Zuccon, Alexandre, et al.
Publicado: (2014)

Partial Loss of Function ABCA12 Mutations Generate Reduced Deposition of Glucosyl-Ceramide, Leading to Patchy Ichthyosis and Erythrodermia Resembling Erythrokeratodermia Variabilis et Progressiva (EKVP)
por: Terrinoni, Alessandro, et al.
Publicado: (2023)

Diagnosis of Myelodysplastic Syndromes: From Immunological Observations to Clinical Applications
por: Simoni, Yannick, et al.
Publicado: (2022)

The immunological role of mesenchymal stromal cells in patients with myelodysplastic syndrome
por: Zheng, Likun, et al.
Publicado: (2022)

The Venetoclax/Azacitidine Combination Targets the Disease Clone in Acute Myeloid Leukemia, Being Effective and Safe in a Patient with COVID-19
por: Cristiano, Antonio, et al.
Publicado: (2022)

Sleep Dysregulation Is Associated with (18)F-FDG PET and Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease
por: Fernandes, Mariana, et al.
Publicado: (2023)

The forkhead box C1 (FOXC1) transcription factor is downregulated in acute promyelocytic leukemia
por: Fabiani, Emiliano, et al.
Publicado: (2017)

Validation of a quantitative lateral flow immunoassay (LFIA)-based point-of-care (POC) rapid test for SARS-CoV-2 neutralizing antibodies
por: Pieri, Massimo, et al.
Publicado: (2022)

Amniotic fluid antiphospholipid antibodies: potential role in antiphospholipid syndrome-independent aberrant implantation process
por: Bruno, Valentina, et al.
Publicado: (2019)

The Antibodies’ Response to SARS-CoV-2 Vaccination: 1-Year Follow Up
por: Nicolai, Eleonora, et al.
Publicado: (2023)

Nuclear Antigens and Auto/Alloantibody Responses: Friend or Foe in Transplant Immunology
por: Nakano, Toshiaki, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jqmavbf2hm26v0d9douacr1mp3